Abstract
Generation of induced pluripotent stem cells by defined factors has become a useful model to investigate the mechanism of reprogramming and cell fate determination. However, the precise mechanism of factor-based reprogramming remains unclear. Here, we show that Klf4 mainly acts at the initial phase of reprogramming to initiate mesenchymal-to-epithelial transition and can be functionally replaced by bone morphogenetic proteins (BMPs). BMPs boosted the efficiency of Oct4/Sox2-mediated reprogramming of mouse embryonic fibroblasts (MEFs) to ∼1%. BMPs also promoted single-factor Oct4-based reprogramming of MEFs and tail tibial fibroblasts. Our studies clarify the contribution of Klf4 in reprogramming and establish Oct4 as a singular setter of pluripotency in differentiated cells.
Similar content being viewed by others
Introduction
Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by ectopic expression of Oct4, Sox2, Klf4 and c-Myc 1, 2, 3, 4, 5, 6. However, the Yamanaka factors included Klf4 and Myc both not directly implicated in pluripotency, but did not have the pluripotency regulator Nanog, suggesting that there is a mechanistic difference between induction and maintenance of pluripotency 1. We recently reported that mouse fibroblasts undergo a mesenchymal-to-epithelial transition (MET) orchestrated by Oct4, Sox2 and Myc to suppress snail expression and blunt TGF-β signaling, and Klf4 to activate expression of epithelial markers, such as Cdh1, during the initial phase of reprogramming 7, thus, defining a concrete molecular and cellular step towards pluripotency 7, 8. The division of labor among the Yamanaka factors suggests that each factor plays distinct roles during the reprogramming process. Taken together, one would expect that Oct4 alone can reprogram somatic cells such as mouse fibroblasts into pluripotency as Oct4 governs embryonic cell fate 9, 10. In this study, we analyzed the relative contribution of Sox2 and Klf4 towards reprogramming under a chemically defined system optimized for robust reprogramming. We showed that Klf4 plays an important role in triggering MET, which can also be initiated by bone morphogenetic proteins (BMPs) 8, 11. Then, we demonstrated that Oct4/Sox2 (OS) and Oct4 alone can reprogram mouse embryonic fibroblasts (MEFs) and tail tibial fibroblasts (TTFs) efficiently in the presence of BMPs.
Results
Klf4 mainly acts at the initial phase of reprogramming
Multifactorial requirement is a great barrier for mechanistic investigation of factor-based reprogramming. However, the function of each factor employed in reprogramming is poorly understood and at least two factors are required (including ectopic and endogenous expression) in the literature 7, 12, 13, 14, 15, 16. Among the four Yamanaka factors, c-Myc was proven dispensable and can be replaced by various methods 17, 18, 19, 20. Oct4, Sox2 and Klf4 are currently considered as indispensable factors, as replacement of them would greatly reduce reprogramming efficiency. OK-mediated reprogramming of mouse fibroblasts was reported with moderate efficiency, by using compounds targeting various pathways such as Bayk8644, CHIR99021, RepSox and A83-01 7, 12, 13, 16, 21. By contrast, OS-mediated reprogramming was reported only with p53-null fibroblasts 14. We previously reported that OKS-mediated reprogramming can be enhanced by the optimized serum-free medium iSF1 19. Further optimization led to improved efficiency of OKS-mediated reprogramming and we found that iPSCs can be generated by either OK or OS with very low efficiency (Supplementary information, Figure S1A) in a newly formulated medium iCD1. The resulting OS or OK iPSCs were similar to ESCs and could be differentiated into three germ layers in teratoma assay as expected (Supplementary information, Figure S1B). Remarkably, OK-mediated reprogramming appeared to be more efficient and more rapid than OS (Supplementary information, Figure S1A).
We then examined the requirement of Klf4 or Sox2 in a doxycycline-inducible system. We found that Klf4 is required mostly during the initial phase of reprogramming (Figure 1A). We performed transcriptomic analysis and showed that Klf4 upregulated genes important for epithelial development (Figure 1B). Consistent with this analysis, OK stimulates robust expression of epithelial markers (such as Cdh1 and Occludin), while OS has little effect on them (Figure 1C). As MET is an early requisite step during the reprogramming of MEFs and as Klf4 participates in MET by activating the epithelial program 7, we conclude that MET is a rate-limiting step in OS-mediated reprogramming (Figure 1D).
BMPs functionally replace Klf4 and support efficient reprogramming with OS
BMPs have been implicated in MET by reversing TGF-β-induced EMT in NP1 cells and reported to enhance MET during reprogramming 8, 11, and thus may functionally substitute Klf4. To test this possibility, we showed that BMP4 and BMP7 can enhance the expression of epithelial genes (Cdh1, EpCAM, etc.) and inhibit the expression of mesenchymal genes (Zeb1, Twist1, etc.) in OS-infected MEFs, but cannot promote epithelial markers further in OK-infected cultures (Figure 2A and 2B and Supplementary information, Figure S2A and S2B). These results indicate that BMPs can trigger MET in OS-induced reprogramming, but cannot further enhance the strong MET activated by Klf4 in OK reprogramming. Consistently, BMP4 greatly improved the kinetics and efficiency of OS reprogramming (up to ∼0.8% at day 15, a 400-fold plus 9 days improvement), but had no effect on OK reprogramming and even had inhibitory effect on OKS reprogramming (Figure 2C and 2D and Supplementary information, Figure S2C). We also showed that BMP2, BMP6, BMP7 and BMP9, similar to BMP4, significantly enhanced the OS-mediated reprogramming (Figure 2E, and Supplementary information, Figure S2D). We also examined the treatment windows of BMP4 in OS-mediated reprogramming and showed that exposure of BMP4 at days 3-9 is most effective (Figure 2F).
We then investigated the role of Cdh1 in OS-mediated reprogramming and showed that knockdown of Cdh1 decreased reprogramming efficiency significantly (Supplementary information, Figure S2E), suggesting that the observed enhancement by BMP4 is Cdh1 dependent. We also tested other compounds including Kenpaullone 22 and showed that none of them can enhance OS-mediated reprogramming (Supplementary information, Figure S2F). As expected, OS-iPSC clones derived with BMP4 expressed pluripotent markers such as Oct4, Nanog, Rex1 and SSEA-1 (Figure 2G). We then showed that these OS iPSCs contributed to the generation of chimeric mice, which underwent germline transmission (Figure 2H), indicating that the OS iPSCs were fully reprogrammed.
BMPs induce efficient Oct4-mediated reprogramming by promoting MET
We then hypothesized that BMPs should enhance Oct4-mediated reprogramming by inducing MET. As in OS-mediated reprogramming, BMP4 and BMP7 improved the expression of Cdh1 and EpCAM in Oct4-transduced MEFs (Figure 3A and Supplementary information, Figure S3A). We then showed that Oct4 alone was able to convert MEFs into iPSCs efficiently in iCD1+BMP4 with reasonable kinetics (∼0.05% at D24 post-infection; Figure 3B). Under the same culture condition, we showed that adult mouse TTFs can also be reprogrammed by Oct4 alone reproducibly, demonstrating that Oct4 is sufficient to induce adult somatic cells to pluripotency (Figure 3C-3E). We also showed that BMPs has no effect on the expression level of p53 and p21 (Supplementary information, Figure S3B) and further showed that no other tested chemical compounds can support Oct4-mediated reprogramming (Supplementary information, Figure S3C).
We then characterized the Oct4-iPSC clones isolated with iCD1+BMP4 and showed that they expressed pluripotent markers Oct4, Nanog, Rex1, SSEA-1, Dppa3 and Dnmt3l (Figure 4A and 4B, and Supplementary information, Figure S3D). All Oct4-iPSC clones that we obtained showed normal karyotypes (Figure 4C). We then characterized the integration of the Oct4 transgene by PCR and confirmed that only the Oct4 transgene was present in all Oct4-iPSC clones examined (Figure 4D). The ectopic retroviruses were silenced in these iPSCs, indicating that they maintain pluripotency without transgene expression (Figure 4E). By global transcriptomic analysis, we showed that Oct4-iPSCs resemble ESCs and are different from MEFs (Figure 4F). The Oct4-iPSCs contributed to chimera mice when injected into blastocysts (Figure 4G and Supplementary information, Figure S3E). Furthermore, we obtained germline transmission of Oct4-iPSCs by breeding the chimeras (Figure 4G). These results demonstrate that the iPSCs generated from MEFs or TTFs with Oct4 alone are fully pluripotent.
We further examined whether the replacement of Klf4 by BMP4 is mediated by the activation of endogenous Klf4 expression and showed that BMP4 does not increase the endogenous Klf4 expression in O-, OK- or OS-transduced MEFs (Supplementary information, Figure S4A). In fact, BMPs did not stimulate endogenous expression of other reprogramming factors (including OKSM and Esrrb 23) during reprogramming (Supplementary information, Figure S4B-S4D). We then examined the expression of TGF-β pathway members during reprogramming and showed that BMPs had inhibitory effect on Tgfbr2 and Tgfbr3, while Klf4 repressed Tgfb1, suggesting that BMPs and Klf4 inhibited the TGF-β pathway through different mechanisms (Supplementary information, Figure S4E). So, we concluded that BMPs replace Klf4 functionally by inducing MET through a mechanism different from activating endogenous reprogramming factors.
Discussion
We showed here that Klf4 works at a rate-limiting MET step in the early phase of reprogramming by inducing epithelial markers, while Oct4 and Sox2 contribute little to this step. Therefore, Klf4 appears to play a more important role than Sox2 during the reprogramming of mouse fibroblasts. We showed that BMPs were able to induce MET in Oct4- or OS-transduced fibroblasts through a different mechanism from Klf4 and can replace Klf4 functionally (Figure 5). Therefore, the effect of BMPs is context dependent on the reprogramming factors used and is beneficial only in the absence of Klf4, suggesting that BMPs are functionally redundant with Klf4 on inducing MET, or Klf4 could inhibit the function of BMPs, similar to the Wnt pathway that has a different effect on reprogramming with or without c-Myc 24. We also showed that although Sox2 is a core transcription factor to maintain pluripotency, it appears to only play an auxiliary role in reprogramming. Since KS could not support the generation of iPSCs (data not shown), the central role of Oct4 became apparent in the reprogramming paradigm (Figure 5). Finally, we showed that Oct4 is sufficient to reprogram MEFs and TTFs at efficiencies similar to that originally reported for Oct4, Sox2, Klf4 and Myc. Therefore, one may speculate that Oct4-mediated reprogramming can be further improved or used for screening small chemicals that can replace Oct4.
Materials and Methods
Cell culture
MEFs were cultured with DMEM+10% FBS and ESCs/iPSCs were cultured with either mES medium (DMEM supplemented with 15% FBS, LIF and other components) or KSR medium (replace the FBS in mES medium with Knockout Serum Replacement). MEF feeder cells were inactivated by mitomycin C. BMP4, BMP7, BMP2, BMP6 and BMP9 were used at final concentrations of 10 ng/ml, 100 ng/ml, 30 ng/ml, 30 ng/ml and 10 ng/ml, respectively. Vitamin C was purchased from Sigma (Cat No. 49752), BMPs from R&D and CHIR99021 was synthesized at GIBH. Rest of the chemicals and reagents were purchased from Invitrogen.
Generation of iPSCs
Plasmids carrying murine Oct4, Klf4, Sox2 and c-Myc cDNA were purchased from Addgene. For direct reprogramming, Oct4-GFP transgenic MEFs were plated at 4 000 cells/cm2 (for OKS combination) or 7 500 cells/cm2 (for other combinations), and then infected with retrovirus packed by plat-E cells for two rounds. After 48 hours, the tested media were added and the day is defined as day 0 post-treatment. iPSCs were induced with iCD1, which is based on DMEM+vitamin C 25 supplemented with bFGF, CHIR99021 and other chemically defined components to support growth. The photos taken by SteREO Lumar.V12 (Zeiss) show the entire well. Reprogramming efficiency was determined by directly scoring the number of Oct4-GFP-positive colonies under microscope.
Blastocyst injection
Resulting iPSCs or ESCs were cultured in mES (containing 15% FBS) or KSR (containing 15% serum replacement). For generation of chimaeras, iPSCs were injected into ICR blastocysts using Piezo Micro Manipulator. Injected blastocysts were transplanted into pseudopregnant ICR females. Germline transmission of resulted chimeric mice was determined by breeding F2 mouse with ICR mouse.
Plasmid construction
The pWP-TetOn vector was constructed by replacing the EF-1α promoter of the pWPXLd vector with the TRE promoter of pTRE-Tight vector (Clontech). M2rtTA from pTet-On Advanced vector (Clontech) was cloned into the pWPXLd vector.
Quantitative RT-PCR
Total mRNA was isolated using TRIzol and then was converted to cDNA. Quantitative PCR was performed and analyzed with ABI 7300. All qRT-PCR results presented in this study were from at least two independent experiments with independent viral preparations.
References
Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663–676.
Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; 448:318–324.
Maherali N, Sridharan R, Xie W, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007; 1:55–70.
Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861–872.
Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318:1917–1920.
Pei D . Regulation of pluripotency and reprogramming by transcription factors. J Biol Chem 2009; 284:3365–3369.
Li R, Liang J, Ni S, et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010; 7:51–63.
Samavarchi-Tehrani P, Golipour A, David L, et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010; 7:64–77.
Scholer HR, Hatzopoulos AK, Balling R, Suzuki N, Gruss P . A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J 1989; 8:2543–2550.
Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998; 95:379–391.
Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9:964–968.
Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S . Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 2008; 3:568–574.
Ichida JK, Blanchard J, Lam K, et al. A small-molecule inhibitor of TGF-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 2009; 5:491–503.
Kawamura T, Suzuki J, Wang YV, et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009; 460:1140–1144.
Kim JB, Sebastiano V, Wu G, et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009; 136:411–419.
Maherali N, Hochedlinger K . Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr Biol 2009; 19:1718–1723.
Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008; 26:101–106.
Judson RL, Babiarz JE, Venere M, Blelloch R . Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol 2009; 27:459–461.
Chen J, Liu J, Han Q, et al. Towards an optimized culture medium for the generation of mouse induced pluripotent stem cells. J Biol Chem 2010; 285:31066–31072.
Wernig M, Meissner A, Cassady JP, Jaenisch R . c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008; 2:10–12.
Li W, Zhou H, Abujarour R, et al. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 2009; 27:2992–3000.
Lyssiotis CA, Foreman RK, Staerk J, et al. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci USA 2009; 106:8912–8917.
Feng B, Jiang J, Kraus P, et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol 2009; 11:197–203.
Marson A, Foreman R, Chevalier B, et al. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 2008; 3:132–135.
Esteban MA, Wang T, Qin B, et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010; 6:71–79.
Acknowledgements
We are grateful to Ronghui Li, Jialiang Liang, Xiangjie Zhao, Kunlun Mo, Shilong Chu, Jieying Zhu, He Liu, Jing Li, Zhicheng Xiang, Wenzhi He, Keyu Lai, Shaoxian Sun, Haijun Xie, Lin Guo, Xiujuan Cai and Hongwen Pang for their technical assistance. We also thank all members of our laboratory for supporting our work. Data of microarray are available on GEO: GSE24930. This work is supported by the National Natural Science Foundation of China (30630039, 30725012, 90813033), MOST 973 program 2009CB941102, Ministry of Science and Technology International Technology Cooperation Program (2010DFB30430), Knowledge Innovation Project of The Chinese Academy of Sciences (KSCX2-YW-R-221,KSCX2-YW-R-244) and Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams.
Author information
Authors and Affiliations
Corresponding author
Additional information
( Supplementary information is linked to the online version of the paper on the Cell Research website.)
Supplementary information
Supplementary information, Figure S1
(A) Summary of reprogramming efficiency with Oct4/Sox2/Klf4 (OSK), OK and OS mediated reprogramming. (PDF 354 kb)
Supplementary information, Figure S2
BMPs promote OS mediated reprogramming by triggering MET. (PDF 319 kb)
Supplementary information, Figure S3
BMPs enhance Oct4 mediated reprogramming. (PDF 339 kb)
Supplementary information, Figure S4
Effect of BMPs on reprogramming factor expression. (PDF 274 kb)
Rights and permissions
About this article
Cite this article
Chen, J., Liu, J., Yang, J. et al. BMPs functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone. Cell Res 21, 205–212 (2011). https://doi.org/10.1038/cr.2010.172
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cr.2010.172
Keywords
This article is cited by
-
Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming
Nature Aging (2023)
-
H3K27ac mediated SS18/BAFs relocation regulates JUN induced pluripotent-somatic transition
Cell & Bioscience (2022)
-
Cellular direct conversion by cell penetrable OCT4-30Kc19 protein and BMP4 growth factor
Biomaterials Research (2022)
-
BMP4 resets mouse epiblast stem cells to naive pluripotency through ZBTB7A/B-mediated chromatin remodelling
Nature Cell Biology (2020)
-
JMJD3 acts in tandem with KLF4 to facilitate reprogramming to pluripotency
Nature Communications (2020)